Cellular Cholesterol Loss Impairs Synaptic Vesicle Mobility via the CAMK2/Synapsin-1 Signaling Pathway

Background: Neuronal cholesterol deficiency may contribute to the synaptopathy observed in Alzheimer’s disease (AD). However, the underlying mechanisms remain poorly understood. Intact synaptic vesicle (SV) mobility is crucial for normal synaptic function, whereas disrupted SV mob...

Full description

Saved in:
Bibliographic Details
Main Authors: Atikam Qurban, Mengqi Zhang, Hengbing Zu, Kai Yao
Format: Article
Language:English
Published: IMR Press 2025-01-01
Series:Frontiers in Bioscience-Landmark
Subjects:
Online Access:https://www.imrpress.com/journal/FBL/30/1/10.31083/FBL27111
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832586499527278592
author Atikam Qurban
Mengqi Zhang
Hengbing Zu
Kai Yao
author_facet Atikam Qurban
Mengqi Zhang
Hengbing Zu
Kai Yao
author_sort Atikam Qurban
collection DOAJ
description Background: Neuronal cholesterol deficiency may contribute to the synaptopathy observed in Alzheimer’s disease (AD). However, the underlying mechanisms remain poorly understood. Intact synaptic vesicle (SV) mobility is crucial for normal synaptic function, whereas disrupted SV mobility can trigger the synaptopathy associated with AD. In this study, we investigated whether cellular cholesterol deficiency affects SV mobility, with the aim of identifying the mechanism that links cellular cholesterol loss to synaptopathy in AD. Methods: Lentiviruses carrying 3β-hydroxysteroid-Δ24 reductase-complementary DNA (DHCR24-cDNA), DHCR24-short hairpin RNA (DHCR24- shRNA) or empty lentiviral vectors were transfected into SHSY-5Y cells in order to construct DHCR24 knock-down and knock-in models, along with corresponding controls. Filipin III cholesterol staining was employed to visualize membrane and intracellular cholesterol in the different cell models, and fluorescence intensity was assessed using confocal microscopy. Additionally, we performed immunoblotting to quantify the expression of DHCR24, total calmodulin-dependent protein kinase 2 (CAMK-2), p-CAMK2 (T286), caveolin-1, total synapsin-1, phosphorylated synapsin-1 (p-synapsin-1; S605), and synaptophysin in each experimental group. Results: In DHCR24-silenced cells, the loss of cellular cholesterol caused by knock-down of DCHR24 resulted in a significant decrease in the levels of phosphorylated CAMK2 (p-CAMK2) and phosphorylated synapsin-1 (p-synapsin-1) compared to control cells. The reduction in p-CAMK2 and p-synapsin-1 could disrupt SV mobility, thereby reducing replenishment of the readily releasable pool (RRP) from the reserve pool (RP). Furthermore, cells with DHCR24 knock-down showed downregulation of caveolin-1, a crucial lipid raft marker, compared to control cells. Conversely, elevated cellular cholesterol levels caused by knock-in of DHCR24 reversed the effects of cholesterol deficiency, suggesting that CAMK2-mediated synapsin-1 phosphorylation may be regulated in a lipid raft-associated manner. Additionally, we found that cellular cholesterol loss could significantly downregulate the expression of synaptophysin protein, which is vital for SV biogenesis and synaptic plasticity. Conclusion: These results suggest that depletion of cellular cholesterol following knock-down of DHCR24 can decrease synaptophysin protein expression and impair SV mobility by regulating the CAMK2-meditated synapsin-1 phosphorylation pathway, potentially via a lipid raft-associated mechanism. Our study indicates a critical role for cellular cholesterol deficiency in AD-related synaptopathy, thus highlighting the potential for targeting cellular cholesterol metabolism in therapeutic strategies.
format Article
id doaj-art-3b0aa674ca6945d9bb8774b1c5e4d8c8
institution Kabale University
issn 2768-6701
language English
publishDate 2025-01-01
publisher IMR Press
record_format Article
series Frontiers in Bioscience-Landmark
spelling doaj-art-3b0aa674ca6945d9bb8774b1c5e4d8c82025-01-25T08:55:53ZengIMR PressFrontiers in Bioscience-Landmark2768-67012025-01-013012711110.31083/FBL27111S2768-6701(24)01601-0Cellular Cholesterol Loss Impairs Synaptic Vesicle Mobility via the CAMK2/Synapsin-1 Signaling PathwayAtikam Qurban0Mengqi Zhang1Hengbing Zu2Kai Yao3Department of Neurology, Jinshan Hospital, Fudan University, 201508 Shanghai, ChinaDepartment of Neurology, Jinshan Hospital, Fudan University, 201508 Shanghai, ChinaDepartment of Neurology, Jinshan Hospital, Fudan University, 201508 Shanghai, ChinaDepartment of Neurology, Jinshan Hospital, Fudan University, 201508 Shanghai, ChinaBackground: Neuronal cholesterol deficiency may contribute to the synaptopathy observed in Alzheimer’s disease (AD). However, the underlying mechanisms remain poorly understood. Intact synaptic vesicle (SV) mobility is crucial for normal synaptic function, whereas disrupted SV mobility can trigger the synaptopathy associated with AD. In this study, we investigated whether cellular cholesterol deficiency affects SV mobility, with the aim of identifying the mechanism that links cellular cholesterol loss to synaptopathy in AD. Methods: Lentiviruses carrying 3β-hydroxysteroid-Δ24 reductase-complementary DNA (DHCR24-cDNA), DHCR24-short hairpin RNA (DHCR24- shRNA) or empty lentiviral vectors were transfected into SHSY-5Y cells in order to construct DHCR24 knock-down and knock-in models, along with corresponding controls. Filipin III cholesterol staining was employed to visualize membrane and intracellular cholesterol in the different cell models, and fluorescence intensity was assessed using confocal microscopy. Additionally, we performed immunoblotting to quantify the expression of DHCR24, total calmodulin-dependent protein kinase 2 (CAMK-2), p-CAMK2 (T286), caveolin-1, total synapsin-1, phosphorylated synapsin-1 (p-synapsin-1; S605), and synaptophysin in each experimental group. Results: In DHCR24-silenced cells, the loss of cellular cholesterol caused by knock-down of DCHR24 resulted in a significant decrease in the levels of phosphorylated CAMK2 (p-CAMK2) and phosphorylated synapsin-1 (p-synapsin-1) compared to control cells. The reduction in p-CAMK2 and p-synapsin-1 could disrupt SV mobility, thereby reducing replenishment of the readily releasable pool (RRP) from the reserve pool (RP). Furthermore, cells with DHCR24 knock-down showed downregulation of caveolin-1, a crucial lipid raft marker, compared to control cells. Conversely, elevated cellular cholesterol levels caused by knock-in of DHCR24 reversed the effects of cholesterol deficiency, suggesting that CAMK2-mediated synapsin-1 phosphorylation may be regulated in a lipid raft-associated manner. Additionally, we found that cellular cholesterol loss could significantly downregulate the expression of synaptophysin protein, which is vital for SV biogenesis and synaptic plasticity. Conclusion: These results suggest that depletion of cellular cholesterol following knock-down of DHCR24 can decrease synaptophysin protein expression and impair SV mobility by regulating the CAMK2-meditated synapsin-1 phosphorylation pathway, potentially via a lipid raft-associated mechanism. Our study indicates a critical role for cellular cholesterol deficiency in AD-related synaptopathy, thus highlighting the potential for targeting cellular cholesterol metabolism in therapeutic strategies.https://www.imrpress.com/journal/FBL/30/1/10.31083/FBL27111alzheimer’s diseasedhcr24cholesterolcamk2synapsin-1synaptic vesiclesynaptopathy
spellingShingle Atikam Qurban
Mengqi Zhang
Hengbing Zu
Kai Yao
Cellular Cholesterol Loss Impairs Synaptic Vesicle Mobility via the CAMK2/Synapsin-1 Signaling Pathway
Frontiers in Bioscience-Landmark
alzheimer’s disease
dhcr24
cholesterol
camk2
synapsin-1
synaptic vesicle
synaptopathy
title Cellular Cholesterol Loss Impairs Synaptic Vesicle Mobility via the CAMK2/Synapsin-1 Signaling Pathway
title_full Cellular Cholesterol Loss Impairs Synaptic Vesicle Mobility via the CAMK2/Synapsin-1 Signaling Pathway
title_fullStr Cellular Cholesterol Loss Impairs Synaptic Vesicle Mobility via the CAMK2/Synapsin-1 Signaling Pathway
title_full_unstemmed Cellular Cholesterol Loss Impairs Synaptic Vesicle Mobility via the CAMK2/Synapsin-1 Signaling Pathway
title_short Cellular Cholesterol Loss Impairs Synaptic Vesicle Mobility via the CAMK2/Synapsin-1 Signaling Pathway
title_sort cellular cholesterol loss impairs synaptic vesicle mobility via the camk2 synapsin 1 signaling pathway
topic alzheimer’s disease
dhcr24
cholesterol
camk2
synapsin-1
synaptic vesicle
synaptopathy
url https://www.imrpress.com/journal/FBL/30/1/10.31083/FBL27111
work_keys_str_mv AT atikamqurban cellularcholesterollossimpairssynapticvesiclemobilityviathecamk2synapsin1signalingpathway
AT mengqizhang cellularcholesterollossimpairssynapticvesiclemobilityviathecamk2synapsin1signalingpathway
AT hengbingzu cellularcholesterollossimpairssynapticvesiclemobilityviathecamk2synapsin1signalingpathway
AT kaiyao cellularcholesterollossimpairssynapticvesiclemobilityviathecamk2synapsin1signalingpathway